Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Feb 10, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | $42.28B | $320.00 | $491.00 | 53.44% | 54.79% | Strong Buy | Strong Buy | 18 | 12 | 37.50% | 307.55% | 1,650.79% | 79.58% |
| THC | TENET HEALTHCARE CORP | $16.96B | $192.96 | $237.15 | 22.90% | 24.55% | Strong Buy | Strong Buy | 13 | 6 | 4.93% | 10.22% | 49.40% | 6.74% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $13.91B | $139.56 | $182.31 | 30.63% | 31.45% | Strong Buy | Strong Buy | 13 | 11 | 15.51% | 44.04% | 44.67% | 31.45% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $10.03B | $165.00 | $213.27 | 29.26% | 29.26% | Strong Buy | Strong Buy | 11 | 11 | 8.99% | N/A | 47.05% | 16.40% |
| VISN | VISTANCE NETWORKS INC | $4.30B | $19.43 | $23.50 | 20.95% | 20.95% | Strong Buy | Strong Buy | 1 | 1 | 19.27% | -62.19% | -20.63% | 6.09% |
| INDV | INDIVIOR PLC | $4.23B | $33.86 | $41.00 | 21.09% | 10.75% | Strong Buy | Strong Buy | 3 | 2 | 1.07% | 40.00% | N/A | N/A |
| RSI | RUSH STREET INTERACTIVE INC | $4.06B | $17.70 | $23.00 | 29.94% | 29.94% | Strong Buy | Strong Buy | 5 | 5 | 25.22% | 64.73% | 123.62% | 27.73% |
| VCYT | VERACYTE INC | $2.90B | $36.73 | $46.33 | 26.14% | 27.96% | Buy | Strong Buy | 6 | 2 | 13.15% | 71.30% | 14.91% | 13.71% |
| HCI | HCI GROUP INC | $2.08B | $160.73 | $245.00 | 52.43% | 46.21% | Strong Buy | Strong Buy | 2 | 1 | 20.62% | -4.56% | 28.21% | 9.88% |
| HLMN | HILLMAN SOLUTIONS CORP | $2.02B | $10.25 | $13.50 | 31.71% | 46.34% | Strong Buy | Strong Buy | 2 | 1 | 6.63% | 62.10% | 16.69% | 8.56% |
| FIVN | FIVE9 INC | $1.33B | $17.04 | $25.67 | 50.63% | 67.25% | Buy | Strong Buy | 6 | 2 | 10.43% | 107.21% | 37.56% | 16.47% |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | $1.24B | $46.62 | $61.50 | 31.92% | 31.92% | Strong Buy | Strong Buy | 2 | 2 | 6.14% | 306.56% | 32.50% | 16.84% |
| TBLA | TABOOLACOM LTD | $1.01B | $3.51 | $6.00 | 70.94% | 70.94% | Strong Buy | Strong Buy | 1 | 1 | 8.49% | 80.93% | 11.61% | 6.92% |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | $857.17M | $30.56 | $40.00 | 30.89% | 30.89% | Strong Buy | Strong Buy | 1 | 1 | -3.47% | -22.98% | 21.46% | 3.44% |
| NRDS | NERDWALLET INC | $746.04M | $10.26 | $16.80 | 63.74% | 63.74% | Strong Buy | Strong Buy | 5 | 5 | 7.83% | 12.21% | N/A | N/A |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | $705.28M | $18.90 | $25.00 | 32.28% | 58.73% | Strong Buy | Strong Buy | 2 | 1 | 178.73% | N/A | N/A | N/A |
| LE | LANDS' END INC | $568.25M | $18.60 | $45.00 | 141.94% | 141.94% | Strong Buy | Strong Buy | 1 | 1 | 5.29% | 125.49% | 13.08% | 3.54% |
| ORGO | ORGANOGENESIS HOLDINGS INC | $486.07M | $3.83 | $9.00 | 134.99% | 134.99% | Strong Buy | Strong Buy | 1 | 1 | 19.14% | N/A | 18.27% | 9.14% |
| LTRX | LANTRONIX INC | $250.85M | $6.32 | $8.25 | 30.54% | 30.54% | Strong Buy | Strong Buy | 2 | 2 | 9.55% | N/A | 18.36% | 11.23% |
| ELMD | ELECTROMED INC | $230.28M | $27.61 | $36.00 | 30.39% | 30.39% | Strong Buy | Strong Buy | 2 | 1 | 10.05% | 11.57% | 20.91% | 17.45% |
| INFU | INFUSYSTEM HOLDINGS INC | $155.78M | $7.66 | $14.50 | 89.30% | 82.77% | Strong Buy | Strong Buy | 2 | 1 | 8.07% | 27.38% | N/A | N/A |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.